跳至主要内容
临床试验/IRCT20120314009297N6
IRCT20120314009297N6招募中3 期

Efficacy and safety evaluation of oral tapering prednisolone following inravenous methyl prednisolone to improve outcome of multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trial

Sari University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • Disability Status Scale (EDSS) 0 to 5.0 before the attack

排除标准

  • Corticosteroid susceptibility
  • Any worsening in symptoms that require a change in treatment
  • Patient with optic neuritis
  • Not complete Period of treatment by the patient
  • A patient with active and bleeding stomach ulcer
  • A patient with diabetes with uncontrolled blood sugar

研究者

发起方
Sari University of Medical Sciences

相似试验